Cargando…

PSME2 identifies immune-hot tumors in breast cancer and associates with well therapeutic response to immunotherapy

Breast cancer (BrCa) is a heterogeneous disease, which leads to unsatisfactory prognosis in females worldwide. Previous studies have proved that tumor immune microenvironment (TIME) plays crucial roles in oncogenesis, progression, and therapeutic resistance in Breast cancer. However, biomarkers rela...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wu, Cen, Zhong, Ren, Sun, Xiaofei, Shi, Jiajie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Genetics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9793949/ https://www.ncbi.nlm.nih.gov/pubmed/36583022 http://dx.doi.org/10.3389/fgene.2022.1071270

Ejemplares similares

CMTM7 recognizes an immune-hot tumor microenvironment and predicts therapeutic response of immunotherapy in breast cancer well
por: Jiang, Xingyu, et al.
Publicado: (2022)

Transcriptome profiles of fatty acid metabolism-related genes and immune infiltrates identify hot tumors for immunotherapy in cutaneous melanoma
por: Dong, Yunxian, et al.
Publicado: (2022)

Tumors escape immunosurveillance by overexpressing the proteasome activator PSME3
por: Boulpicante, Mathilde, et al.
Publicado: (2020)

GBP5 Identifies Immuno-Hot Tumors and Predicts the Therapeutic Response to Immunotherapy in NSCLC
por: Fan, Honghong, et al.
Publicado: (2023)

N6-methyladenosine Regulator-Mediated Immune Genes Identify Breast Cancer Immune Subtypes and Predict Immunotherapy Efficacy
por: Zhang, Meng-Meng, et al.
Publicado: (2021)

PSME4 Degrades Acetylated YAP1 in the Nucleus of Mesenchymal Stem Cells
por: Kim, Yong Sook, et al.
Publicado: (2022)

Tumor Microenvironment Analysis Identified Subtypes Associated With the Prognosis and the Tumor Response to Immunotherapy in Bladder Cancer
por: Zhang, Hongxian, et al.
Publicado: (2021)

Triple negative breast cancer: Immunogenicity, tumor microenvironment, and immunotherapy
por: Loizides, Sotiris, et al.
Publicado: (2023)

Tumor Characterization in Breast Cancer Identifies Immune-Relevant Gene Signatures Associated With Prognosis
por: Li, Jie, et al.
Publicado: (2019)

PSME4 Activates mTOR Signaling and Promotes the Malignant Progression of Hepatocellular Carcinoma
por: Ge, Sijia, et al.
Publicado: (2022)

The Proteasome Activator PA200/PSME4: An Emerging New Player in Health and Disease
por: Yazgili, Ayse Seda, et al.
Publicado: (2022)

Prognostic implication and immunotherapy response prediction of a ubiquitination-related gene signature in breast cancer
por: Guo, Yangyang, et al.
Publicado: (2023)

Corrigendum: Prognostic implication and immunotherapy response prediction of a ubiquitination-related gene signature in breast cancer
por: Guo, Yangyang, et al.
Publicado: (2023)

Dusp3 and Psme3 Are Associated with Murine Susceptibility to Staphylococcus aureus Infection and Human Sepsis
por: Yan, Qin, et al.
Publicado: (2014)

T cell proliferation-related genes: Predicting prognosis, identifying the cold and hot tumors, and guiding treatment in clear cell renal cell carcinoma
por: Huang, Haoran, et al.
Publicado: (2022)

Lactate score predicts survival, immune cell infiltration and response to immunotherapy in breast cancer
por: Yin, Ting-Ting, et al.
Publicado: (2022)

Identification of immune-related signature for the prognosis and benefit of immunotherapy in triple-negative breast cancer
por: Sun, Xiaorui, et al.
Publicado: (2022)

The Chemokines Initiating and Maintaining Immune Hot Phenotype Are Prognostic in ICB of HNSCC
por: Huang, Yuhong, et al.
Publicado: (2022)

Comprehensive analysis of PTPN gene family revealing PTPN7 as a novel biomarker for immuno-hot tumors in breast cancer
por: Wang, Fengxu, et al.
Publicado: (2022)

Identifying Gene–Environment Interactions With Robust Marginal Bayesian Variable Selection
por: Lu, Xi, et al.
Publicado: (2021)

Immunogenic cell death-related classifications in breast cancer identify precise immunotherapy biomarkers and enable prognostic stratification
por: Wang, Xue, et al.
Publicado: (2022)

Correction: Dusp3 and Psme3 Are Associated with Murine Susceptibility to Staphylococcus aureus Infection and Human Sepsis
Publicado: (2014)

A Novel Immune-Gene Pair Signature Revealing the Tumor Microenvironment Features and Immunotherapy Prognosis of Muscle-Invasive Bladder Cancer
por: Zheng, Xiaonan, et al.
Publicado: (2021)

Predicting prognosis and immunotherapy response among colorectal cancer patients based on a tumor immune microenvironment-related lncRNA signature
por: Hu, Chuling, et al.
Publicado: (2022)

Comprehensive Analysis of Tumor Immune Microenvironment Characteristics for the Prognostic Prediction and Immunotherapy of Oral Squamous Cell Carcinoma
por: Zhao, Yijie, et al.
Publicado: (2022)

Critical role of guanylate binding protein 5 in tumor immune microenvironment and predictive value of immunotherapy response
por: Li, Xiang, et al.
Publicado: (2022)

A novel immune signature predicts immunotherapy responsiveness and reveals the landscape of the tumor immune microenvironment in head and neck squamous cell carcinoma
por: Wang, Qiwei, et al.
Publicado: (2022)

Construction of a novel prognostic signature based on the composition of tumor-infiltrating immune cells in clear cell renal cell carcinoma
por: Yu, Weiwei, et al.
Publicado: (2022)

Editorial: The role of immunophenotype in tumor immunotherapy response
por: Qin, Yujuan, et al.
Publicado: (2023)

PSME3 Promotes TGFB1 Secretion by Pancreatic Cancer Cells to Induce Pancreatic Stellate Cell Proliferation
por: Yu, Lianyuan, et al.
Publicado: (2019)

PSME4 determines mesenchymal stem cell fate towards cardiac commitment through YAP1 degradation
por: Kim, Mira, et al.
Publicado: (2023)

Integrated Bioinformatics Analysis Identifies Heat Shock Factor 2 as a Prognostic Biomarker Associated With Immune Cell Infiltration in Hepatocellular Carcinoma
por: Fan, Yumei, et al.
Publicado: (2021)

Biological characteristics of γδT cells and application in tumor immunotherapy
por: Zhu, Renhong, et al.
Publicado: (2023)

Macrophage-related molecular subtypes in lung adenocarcinoma identify novel tumor microenvironment with prognostic and therapeutic implications
por: Wen, Heng, et al.
Publicado: (2022)

Downregulated miR-585-3p promotes cell growth and proliferation in colon cancer by upregulating PSME3
por: Liu, Chunmei, et al.
Publicado: (2019)

Pan-cancer analysis identifies proteasome 26S subunit, ATPase (PSMC) family genes, and related signatures associated with prognosis, immune profile, and therapeutic response in lung adenocarcinoma
por: Jia, Hui, et al.
Publicado: (2023)

Comprehensive Analysis of Tumor Microenvironment Identified Prognostic Immune-Related Gene Signature in Ovarian Cancer
por: Li, Na, et al.
Publicado: (2021)

Identifying Hypoxia Characteristics to Stratify Prognosis and Assess the Tumor Immune Microenvironment in Renal Cell Carcinoma
por: Zhang, Zhenan, et al.
Publicado: (2021)

Identification of RNA Methylation-Related lncRNAs Signature for Predicting Hot and Cold Tumors and Prognosis in Colon Cancer
por: He, Rong, et al.
Publicado: (2022)

N7-methylguanosine-related lncRNAs: Predicting the prognosis and diagnosis of colorectal cancer in the cold and hot tumors
por: Wu, Jing-Yu, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_vmpfpfur1qt7omvf51fkklf798